These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 3590890)
1. [Problems in internal medicine therapy of breast cancer]. Reinhardt U; Wolf H; Müller C Z Gesamte Inn Med; 1987 Mar; 42(5):134-7. PubMed ID: 3590890 [TBL] [Abstract][Full Text] [Related]
2. [Primary chemotherapy in operable breast carcinoma]. Bonadonna G; Valagussa P Ann Ital Chir; 1999; 70(3):359-69. PubMed ID: 10466239 [TBL] [Abstract][Full Text] [Related]
3. [Hormone therapy and chemotherapy of metastasizing breast cancer. Experiences of the Basle Oncology Center, 1969-72]. Byland W; Nagel G; Senn HJ Schweiz Med Wochenschr; 1974 Aug; 104(31):1077-85. PubMed ID: 4445838 [No Abstract] [Full Text] [Related]
4. [Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)]. Michlmayr G; Kratzer H; Denz H; Huber H Wien Klin Wochenschr; 1981 Mar; 93(6):205-7. PubMed ID: 7281697 [TBL] [Abstract][Full Text] [Related]
5. [Hormone therapy of metastasizing breast cancer with tamoxifen]. Köhler A; Noss W; Dobberstein N; Stoltmann R; Pohl J Z Gesamte Inn Med; 1986 Jan; 41(1):6-9. PubMed ID: 3953121 [TBL] [Abstract][Full Text] [Related]
6. [Study of long-term survivors after treatment of thoracic metastases from breast cancer by hormone therapy and nonhormonal antineoplastic chemotherapy combined from the onset]. Mannes P; Derriks R; Moens R Rev Tuberc Pneumol (Paris); 1972; 36(3):460-4. PubMed ID: 5080970 [No Abstract] [Full Text] [Related]
7. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients]. Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583 [TBL] [Abstract][Full Text] [Related]
8. The role of primary chemotherapy in early breast cancer. Harris L; Swain SM Semin Oncol; 1996 Feb; 23(1 Suppl 2):31-42. PubMed ID: 8614843 [TBL] [Abstract][Full Text] [Related]
9. [Metastasizing carcinoma of the breast and diabetes mellitus, a prognostically favourable combination (author's transl)]. Rhomberg W Dtsch Med Wochenschr; 1975 Nov; 100(47):2422-7. PubMed ID: 1183356 [TBL] [Abstract][Full Text] [Related]
10. Survival impact of integrative cancer care in advanced metastatic breast cancer. Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J Breast J; 2009; 15(4):357-66. PubMed ID: 19470134 [TBL] [Abstract][Full Text] [Related]
11. Adjuvant therapy for breast cancer. NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506 [TBL] [Abstract][Full Text] [Related]
12. [Simultaneous radiochemotherapy in locoregional recurrent breast carcinoma after mastectomy. Results in patients with macroscopic residual tumor R2]. Renner H; van Kampen M Strahlenther Onkol; 1994 Aug; 170(8):441-52. PubMed ID: 8085210 [TBL] [Abstract][Full Text] [Related]
13. [Combined drug/hormone therapy in metastatic breast cancer with vincristine, adriamycin, cyclophosphamide and high dose medroxyprogesterone acetate--VAC-MAP. Preliminary results of a phase II study of the German Cancer Society's Internal Medicine Oncology Task Force]. Wander HE; Nagel GA; Blossey HC; Kordilla F; Stamm S; Matthressen W; Weiss J Onkologie; 1982 Aug; 5 Suppl():8-12. PubMed ID: 6752794 [TBL] [Abstract][Full Text] [Related]
14. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer. Klaassen U; Wilke H; Seeber S Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897 [TBL] [Abstract][Full Text] [Related]
15. Isolate local failure after breast-conserving treatment for early breast cancer, about 57 cases. Deniaud-Alexandre E; Lauratet B; Lefranc JP; Genestié C; Lerouge D; Moureau-Zabotto L; Touboul E Cancer Radiother; 2004 Apr; 8(2):95-107. PubMed ID: 15063877 [TBL] [Abstract][Full Text] [Related]
16. [Systemic adjuvant therapy of breast cancer: myths and controversies]. Roy JA; Piccart MJ Rev Med Brux; 1996 Sep; 17(4):267-70. PubMed ID: 8927859 [TBL] [Abstract][Full Text] [Related]
17. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000. National Institutes of Health Consensus Development Panel J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast. Botti C; Vici P; Lopez M; Scinto AF; Cognetti F; Cavaliere R J Am Coll Surg; 1995 Sep; 181(3):202-8. PubMed ID: 7670678 [TBL] [Abstract][Full Text] [Related]
19. Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide: prognostic and therapeutic implications. Karlsson YA; Malmström PO; Hatschek T; Fornander TG; Söderberg M; Bengtsson NO; Jansson TE; Sjöberg SM; Bergh JC Cancer; 1998 Sep; 83(5):936-47. PubMed ID: 9731898 [TBL] [Abstract][Full Text] [Related]
20. On the relevance of "second-line" cytotoxic chemotherapy in patients with metastatic breast cancer resistant to standard combinations. Petru E; Schmähl D Wien Klin Wochenschr; 1986 Dec; 98(23):790-7. PubMed ID: 3811371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]